503A vs. 503B Epicur Pharma FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog FDA Peptide Reclassification 2026: What Researchers Want Is BPC 157 Banned? Oral vs. Injectable Forms Explained The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner